Weight Loss Will Decrease with Python Blood! New Drug Discovery, No Side Effects
Scientists have discovered a molecule in python blood that controls appetite without side effects, offering a new potential way to combat obesity.
Goodbye to Obesity? A Molecule in Snake Blood Promises a Revolution in Weight Loss Drugs
Researchers have discovered a molecule in snake blood that could lead to breakthrough treatments for obesity by effectively regulating appetite and energy without adverse side effects.
Finnish Forestry Giant Addressed Employee Obesity: Here’s What Happened
Stora Enso, a Finnish forestry company, has reported positive results from a program aimed at addressing employee obesity through a combination of medical treatment and lifestyle counseling.
Videos from g1 Bahia and TV Bahia - Sunday, March 22, 2026
The article covers various news topics including the Brazilian electoral court, the ongoing conflict in Iran, drug consumption trends, crowdfunding among medical students, potential obesity treatments from python blood molecules, and the final day of Lollapalooza 2026.
Riina Raudne: avoiding obesity is a significant effort or even a miracle today
Sociologist Riina Raudne discusses the challenges of preventing obesity, highlighting the impact of modern convenience and food environments on lifestyle choices.
Molecule in the blood of pythons reduces appetite and may inspire new drugs against obesity, research indicates
Researchers discover that a molecule in the blood of pythons could lead to new, side-effect-free obesity treatments.
Do pythons have the 'antidote' against human obesity?
Scientists discovered a molecule in pythons that could lead to new anti-obesity drugs after observing its effects on obese mice.
Wegovy HD: higher dose of semaglutide approved by US agency to treat obesity
The FDA has approved a higher dose of Wegovy (semaglutide) for treating obesity, with Novo Nordisk anticipating similar approval in Brazil.
Ozempic in the SUS and without a patent: how weight-loss pens have already changed the world — and what’s to come
Rio de Janeiro has become the first Brazilian city to offer the medication Ozempic through the Unified Health System (SUS) as part of its initiative in the fight against obesity.
Discoveries indicate that pythons could help with weight loss
Researchers have found that metabolites in pythons could inspire new obesity therapies by regulating appetite.
For those over 45: a new study reveals why waistlines increase after this age
A new study published in Science sheds light on why waistlines tend to increase in both men and women after the age of 45, attributing it to cellular processes activated by aging.
Ozempic in the SUS and without a patent: how weight loss pens have changed the world and what lies ahead
Rio de Janeiro becomes the first city in Brazil to offer the medication Ozempic through its public health system, marking a significant step in the fight against obesity.
India to tackle global obesity with cheap fat-loss jabs
India is set to release low-cost generic weight-loss injections following the expiration of key patents, which is expected to make such treatments more accessible globally.
Obesity medication linked to better mental health
A study reveals that semaglutide, an active ingredient in diabetes and obesity medication, is associated with reduced sickness absence and healthcare needs due to mental health issues in over 95,000 Swedes.
Hit drug with a new property: Positive effect on depression and anxiety
A new study reveals that GLP-1 medications, used for obesity treatment, may also positively impact symptoms of depression and anxiety.
The effects of the "Ozempic family" on mental health: lower risk of anxiety and depression
A new study suggests that GLP-1 agonists, commonly used for diabetes and obesity, may also help reduce the risk of anxiety and depression.
Anvisa approves multidose version of Mounjaro for type 2 diabetes and obesity
Brazil's Anvisa has approved a multidose version of the diabetes and obesity medication Mounjaro, allowing for multiple uses from a single vial.
A Solution to Obesity is Hoped for in Python Blood
Researchers believe they have identified a molecule in python blood that can significantly influence metabolism, potentially aiding in the development of a new type of weight-loss drug.
Stopping eating sweet foods for six months does not decrease cravings or improve some health indicators, says a new study
A new clinical trial indicates that eliminating sweet foods from the diet for six months does not reduce cravings or lead to weight loss, challenging public health recommendations.
Universalization of care is a challenge for treating diabetes in the SUS, experts say
Experts highlight the challenges faced by Brazil's public health system (SUS) in providing effective diabetes care amidst rising incidences of the disease and related health issues.
A stronger drug than oral Wigovi has been released... Global competition is intensifying
The global obesity drug market is rapidly shifting from injectable treatments to oral medications, marking a possible disruption to the dominance of Novo Nordisk and Eli Lilly.
From Memory Problems to Heart Damage and Obesity: The Effects of Wartime Routine on the Body Are Already Here
The article discusses the physical and mental health impacts of living in a constant state of alarm and disruption due to an ongoing conflict.
The Insidious Reason for Weight Gain – A Little-Known Disorder Makes Finns Gain Weight, But the Right Diagnosis Could Change Everything
A significant number of overweight Finns suffer from an often-unrecognized disorder that contributes to weight gain, highlighting the importance of proper diagnosis and treatment.
What does the study say that associates weight loss pens with the reduction of anxiety and depression
A recent study suggests that diabetes and obesity treatment pens may also help reduce anxiety and depression.
How the expiration of the Ozempic patent in India could change the global fight against obesity (and what the risks are)
The expiration of the semaglutide patent in India could lead to more affordable weight loss drugs, making them accessible to a larger population.
Ozempic and Wegovy: India's cheap weight-loss pens that could change the global battle against obesity
India is expected to reduce obesity rates significantly with the impending expiration of the semaglutide patent, allowing for cheaper generic versions of popular weight-loss drugs.
The H-hour for obesity drugs is Friday
The patent for the obesity treatment drug semaglutide will expire in India on Friday, leading to potential price reductions and increased market competition.
Ozempic and Wegovy: The Cheap Weight Loss Pens from India That Could Change the Global Fight Against Obesity
India is poised to significantly lower obesity rates with the upcoming expiration of the semaglutide patent, allowing local pharmaceutical companies to produce cheaper generic versions of Ozempic and Wegovy.
A New Formula for Weight Loss, Body Fat Will Melt Without Exercise
A recent scientific study reveals a new approach to weight loss that involves the body's brown fat cells, which generate heat and burn calories rather than simply storing energy.
Did you dream something like this? It may reveal sleep apnea
The article discusses sleep apnea, a condition characterized by nighttime breathing interruptions, and highlights its prevalence in Finland, potential dangers if left untreated, and how certain dream patterns may indicate its presence.
What is known about users of weight loss drugs – official medication may cost three thousand euros a year
A report reveals that the majority of weight loss drug users in Finland are likely working and relatively affluent, with significant financial implications for the usage of these medications.
The wear and tear of the body: the other epidemic affecting productivity and health in Mexico
Musculoskeletal disorders are increasingly affecting productivity and quality of life in Mexico, exacerbated by sedentary lifestyles and inadequate healthcare.
Ozempic: With the expiration of the patent will prices fall? Will we have a generic version? See what to expect now
The patent on semaglutide, the active ingredient in Ozempic, expires in Brazil, possibly leading to lower prices and generic versions of the drug in the future.
No to subsidy - Novo Nordisk appeals
Novo Nordisk is appealing a decision against subsidizing its obesity drug Wegovy in Sweden.
The other side of Ozempic: weight can return quickly
The use of the obesity drug Ozempic is growing in Finland, but experts warn that weight may return quickly without long-term lifestyle changes.
Does Marriage Increase Weight? The Chemistry of Love and Food Reveals the Secret
Research indicates that while marriage can be linked to healthier lifestyles, it may also lead to weight gain and higher obesity rates among couples.
Sales of these medications have exploded
The usage of obesity medications has significantly increased in Finland, with a notable rise in the purchase of semaglutide among patients in 2025.
The Use of Obesity Medications Exploded - Here's How Many Users There Were Last Year
The use of obesity medications in Finland surged by 43% in 2025, with approximately 108,000 people purchasing these drugs, primarily driven by the increasing uptake of semaglutide.
Nigeria ranks lowest among 20 countries lacking obesity care guidelines
Nigeria ranks last in a global index assessing obesity care guidelines, scoring zero in key areas such as obesity management and physical activity.
Uganda Faces Silent Nutrition Crisis, Experts Urge Action in Workplaces
Uganda is experiencing a hidden nutrition crisis characterized by rising obesity and lifestyle diseases, prompting experts to call for immediate action in workplaces.
Ozempic and the rebound effect, what happens a year later?
A study from the University of Cambridge reveals that one year after stopping weight loss medications like Ozempic, individuals tend to regain about 60% of their lost weight, with a stabilization of rebound effects thereafter.
Grief for Gogo: 14-year-old loses her life due to medical error - The father seeks at least an apology
A 14-year-old girl named Gogo died following a surgery for childhood obesity, prompting her priest father to demand accountability from the medical professionals involved.
The obesity wave could soon hit Finland – This is where it strikes first
Elsi Katainen, a Member of the European Parliament, discusses the impacts of the Mercosur trade agreement on Finland, highlighting concerns and unexpected outcomes.
Yo-yo effect after weight loss medications? Researchers notice one important rule
A study by students at Trinity College, Cambridge, has revealed that patients often regain weight after stopping popular weight-loss medications.
Yo-yo effect after weight loss medications? Researchers noticed one important regularity
A study from Trinity College, Cambridge reveals that weight regain is common after discontinuing popular weight loss medications, raising important considerations for patients.
Hospitals deny having a closed agreement with Novo Nordisk to provide Wegovy through the SUS
Hospitals mentioned by Novo Nordisk have denied any formal agreement to provide the obesity drug Wegovy through Brazil's public health system, the SUS.
Window cleaner takes life-changing action after becoming too 'terrified' to sleep
Graham Baalham, a window cleaner from Bury St Edmunds, overcame his fear of dying in his sleep by losing 17 stone and reclaiming his health and vitality.
For those counting steps – scientists' message: helps prevent cancer and diabetes
A recent Lithuanian study found that regularly walking 8,000 to 9,000 steps per day can significantly reduce the risk of obesity, hypertension, and diabetes.
Shocking fitness figures: Finns losing the ability to perform physical jobs
A new physical fitness index indicates a significant decline in the physical health and fitness levels of Finnish people over the past 40 years, with two-thirds of men categorized as overweight or obese.
'I thought I was fit at 28st - grim wake-up call made me shed more than half'
Graham Baalham, a 55-year-old window cleaner from the UK, shares his transformative weight loss journey after a near-death experience at 28 stones.